Activation of T lymphocytes by polysaccharide-protein complex from Lycium barbarum L.

International Immunopharmacology

Volumn 8, Issue 12, 2008, Pages 1663-1671

  Chen, Zhisong ^a   Kwong Huat Tan, Benny ^a   Chan, Soh Ha ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CD25; Cytokine; Lycium barbarum polysaccharide protein complex; T lymphocytes; Transcription factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LYCIUM BARBARUM EXTRACT; POLYSACCHARIDE; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR NFAT3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL CYCLE; CYTOKINES; DRUGS, CHINESE HERBAL; FEMALE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NFATC TRANSCRIPTION FACTORS; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 54549116057     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.07.019     Document Type: Article

References (26)

1. Huang L.J., Lin Y., Tian G.Y., and Ji G.Z. Isolation, purification and physico-chemical properties of immunoactive constituents from the fruit of Lycium barbarum L. Acta Pharma Sinica 33 (1998) 512-516
2. Gan L., Zhang S.H., Liu Q., and Xu H.B. A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells. Eur J Pharmacol 471 (2003) 217-222
3. Gan L., Zhang S.H., Yang X.L., and Xu H.B. Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum. Int Immunopharmacol 4 (2004) 563-569
4. Peng X.M., and Tian G.Y. Structural characterization of the glycan part of glycoconjugate LbGp2 from Lycium barbarum L. Carbohydr Res 331 (2001) 95-99
5. Qin X., Yamauchi R., Aizawa K., Inakuma T., and Kato K. Structural features of arabinogalactan-proteins from the fruit of Lycium chinense Mill. Carbohydr Res 333 (2001) 79-85
6. Tzianabos A.O. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 13 (2000) 523-533
7. Ha K.T., Yoon S.J., Choi D.Y., Kim D.W., Kim J.K., and Kim C.H. Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol 96 (2005) 529-535
8. Luo Q., Cai Y., Yan J., Sun M., and Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci 76 (2004) 137-149
9. Gong H., Shen P., Jin L., Xing C., and Tang F. Therapeutic effects of Lycium barbarum polysaccharide (LBP) on irradiation or chemotherapy-induced myelosuppressive mice. Cancer Biother Radiopharm 20 (2005) 155-162
10. Gong H., Shen P., Jin L., Xing C., and Tang F. Therapeutic effects of Lycium barbarum polysaccharide (LBP) on mitomycin C (MMC)-induced myelosuppressive mice. J Exp Ther Oncol 4 (2004) 181-187
11. Zhang M., Chen H., Huang J., Li Z., Zhu C., and Zhang S. Effect of Lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis. Life Sci 76 (2005) 2115-2124
12. Chao J.C., Chiang S.W., Wang C.C., Tsai Y.H., and Wu M.S. Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells. World J Gastroenterol 12 (2006) 4478-4484
13. Murphy K.M., and Reiner S.T. The lineage decisions of helper T cells. Nat Rev Immunol 2 (2002) 933-944
14. Snyder J.T., Alexander-Miller M.A., Berzofskyl J.A., and Belyakov I.M. Molecular mechanisms and biological significance of CTL avidity. Curr HIV Res 1 (2003) 287-294
15. Dubois M., Pigman W., Hamilton J.K., Rebers P.A., and Smith F. Colorimetric method for determination of sugars and related substances. Ann Chem 28 (1956) 350-356
16. + cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle. Infect Immun 73 (2005) 1321-1329
17. Brian A.A. Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc Natl Acad Sci USA 85 (1988) 564-568
18. Sancho R., Macho A., La Vega L., Calzado M.A., Fiebich B.L., Appendino G., et al. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways. J Immunol 172 (2004) 2341-2351
19. Miyazaki T., Liu Z.J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., et al. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81 (1995) 223-231
20. Decker T., Müller M., and Stockinger S. The yin and yang of type 1 interferon activity in bacterial infection. Nat Rev Immunol 19 (2005) 1-13
21. Weber M.L., and Krammer P. Regulation of IL-4 gene expression by T cells and the therapeutic perspectives. Nat Rev Immunol 3 (2003) 534-543
22. Jankovic D., Sher A., and Yap G. Th1/Th2 effector choice parasitic infection: decision making by committee. Curr Opin Immunol 13 (2001) 403-409
23. Shaw J.P., Utz P.J., Durand D.B., Toole J.J., Emmel E.A., and Crabtree G.R. Identification of a putative regulator of early T cell activation genes. Science 241 (1988) 202-205
24. Macian F., Lopez-Rodriguez C., and Rao A. Partners in transcription: NFAT and AP-1. Oncogene 20 (2001) 2476-2489
25. Jain J., McCaffrey P.G., Valge-Archer V.E., and Rao A. Nuclear factor of activated T cells contains Fos and Jun. Nature 356 (1992) 801-804
26. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5 (2005) 749-759